Testosterone, Sexual Offense Recidivism, and Treatment Effect Among Adult Male Sex Offenders

  • Lea H. Studer
  • A. Scott Aylwin
  • John R. Reddon


The relationship between serum testosterone and sexual violence was examined in a sample of 501 convicted adult male sex offenders attending an intensive in-hospital group psychotherapy treatment program. It was found that men with higher testosterone tended to have committed the most invasive sexual crimes (p < .001, two-tailed). Further, a positive partial correlation (controlling for age) between testosterone and sexual offense recidivism over a lengthy follow-up period (mean = 8.9 years) was found. When the sample was separated into one group that completed treatment and one group that did not, an important ameliorating treatment effect was observed. Although controlling for age, serum testosterone remained significantly predictive of sexual recidivism for the treatment noncompleter group (p < .05, two-tailed). For those who completed treatment testosterone was no longer predictive of sexual reoffense (p > .05, two-tailed). Among convicted sex offenders, higher serum testosterone appears to be associated with greater likelihood of further sexual violence. Effective therapy, however, appears able to intercede in the influence of testosterone on sexually deviant behavior. It is suggested that serum testosterone may be an informative static risk factor and completion of intensive treatment should be accorded significance in future actuarially based risk prediction instruments.


testosterone sex offenders recidivism treatment effect 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aldercreutz, H. (1990). Western diet and western diseases: Some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical and Laboratory Investigation, 50, 3–23.Google Scholar
  2. Archer, J. (1991). The influence of testosterone on human aggression. British Journal of Psychology, 82, 1–28.PubMedGoogle Scholar
  3. Archer, J., Birring, S. S, & Wu, F. C. W. (1998). The association between testosterone and aggression among young men: Empirical findings and a meta-analysis. Aggressive Behavior, 24, 411–420.Google Scholar
  4. Archer, J., Graham-Kevan, N., & Davies, M. (in press). Testosterone and aggression: A reanalysis of Book, Starzyk, and Quinsey’s (2001) study. Aggression and Violent Behavior.Google Scholar
  5. Auger, A. P. (2004). Steroid receptor control of reproductive behavior. Hormones and Behavior, 45, 168–172.PubMedGoogle Scholar
  6. Aylwin, A. S., Clelland, S. R., Kirkby, L. K., Reddon, J. R., Studer, L. H., & Johnston, J. (2000). Sexual offense severity and victim gender preference: A comparison of adolescent and adult sex offenders. International Journal of Law and Psychiatry, 23, 113–124.PubMedGoogle Scholar
  7. Baulieu, E. E., Alberga, A., Jung, I., Lebeau, M. C., Mercier-Bodard, C., Milgrom, E., et al. (1971). Metabolism and protein binding of sex steroids in target organs: An approach to the mechanism of hormone action. Recent Progress in Hormone Research, 27, 351–412.PubMedGoogle Scholar
  8. Book, A. S., Starzyk, K. B., & Quinsey, V. L. (2001). The relationship between testosterone and aggression: A meta-analysis. Aggression and Violent Behavior, 6, 579–599.Google Scholar
  9. Brody, A. L., Saxena, S., Stoessel, P., Gillies, L. A., Fairbanks, L. A., Alborzian, S., et al. (2001). Regional brain metabolic change in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Archives of General Psychiatry, 58, 631–640.PubMedGoogle Scholar
  10. Brooks, J. H., & Reddon, J. R. (1996). Serum testosterone in violent and non-violent young offenders. Journal of Clinical Psychology, 52, 475–483.PubMedGoogle Scholar
  11. Brown, T. R. (1999). Androgen metabolism and action. In C. Wang (Ed.), Male reproductive function (pp. 65–84). Boston: Kluwer.Google Scholar
  12. Couwenbergs, C., Knussmann, R., & Christiansen, K. (1986). Comparisons of the intra- and inter-individual variation in sex hormone levels of men. Annals of Human Biology, 13, 63–72.PubMedGoogle Scholar
  13. Conn, P. M., & Crowley, W. F., Jr. (1991). Gonadotropin-releasing hormone and its analogues. New England Journal of Medicine, 324, 93–103.PubMedGoogle Scholar
  14. Dabbs, J. M., Jr., & Morris, R. (1990). Testosterone, social class, and antisocial behavior in a sample of 4,462 men. Psychological Science, 1, 209–211.Google Scholar
  15. Ehrenkranz, J., Bliss, E., & Sheard, M. (1974). Plasma testosterone: Correlation with aggressive behavior and social dominance in man. Psychosomatic Medicine, 36, 469–475.Google Scholar
  16. Ekins, R. (1990). Measurement of free hormones in blood. Endocrine Reviews, 11, 5–46.PubMedGoogle Scholar
  17. Ellis, L. (1986). Evidence of neuroandrogenic etiology of sex roles from a combined analysis of human, nonhuman primate and nonprimate mammalian studies. Personality and Individual Differences, 7, 519–552.Google Scholar
  18. Ellis, L., & Nyborg, J. (1992). Racial/ethnic variations in male testosterone levels. Steroids, 57, 72–75.PubMedGoogle Scholar
  19. Furmark, T., Tillfors, M., Marteinsdottir, I., Fischer, H., Pissiota, A., Langstrom, B., et al. (2002). Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive behavioral therapy. Archives of General Psychiatry, 59, 425–433.PubMedGoogle Scholar
  20. Gladue, B. A., Boechler, M., & McCaul, K. D. (1989). Hormonal response to competition in human males. Aggressive Behavior, 15, 409–422.Google Scholar
  21. Goldapple, K., Segal, Z., Garson, C., Lau, M. Bieling, P., Kennedy, S., et al. (2004). Modulation of cortical-limbic pathways in major depression. Treatment specific effects of cognitive behavior therapy. Archives of General Psychiatry, 61, 34–41.PubMedGoogle Scholar
  22. Griffin, J. E., & Wilson, J. D. (1992). Disorders of the testes and male reproductive tract. In J. D. Wilson & D. W. Foster (Eds.), Williams textbook of endocrinology (8th ed., pp. 799–852). London: Saunders.Google Scholar
  23. Hanson, R. K. (1997). The development of a brief actuarial risk scale for sexual offense recidivism (User Report No. 97-04). Ottawa, Ontario, Canada: Department of the Solicitor General of Canada.Google Scholar
  24. Hanson, R. K. (2000). Risk assessment. Beaverton, OR: Association for the Treatment of Sexual Abusers.Google Scholar
  25. Hanson, R. K., & Bussière, M. T. (1998). Predicting relapse: A meta-analysis of sexual offender recidivism studies. Journal of Consulting and Clinical Psychology, 66, 348–362.PubMedGoogle Scholar
  26. Harris, J. A. (1999). Review and methodological considerations in research on testosterone and aggression. Aggression and Violent Behavior, 4, 273–291.Google Scholar
  27. Keller, E. T., Ershler, W. B., & Chang, C. (1996). The androgen receptor: A mediator of diverse responses. Frontiers in Bioscience, 1, 59–71.Google Scholar
  28. Kraemer, H. C., Becker, H., Brodie, H., Doering, C., Moos, R., & Hamburg, D. (1976). Orgasmic frequency and plasma testosterone levels in normal males. Archives of Sexual Behavior, 2, 125–132.Google Scholar
  29. Mazur, A., & Booth, A. (1998). Testosterone and dominance in men. Behavioral and Brian Sciences, 21, 353–397.Google Scholar
  30. Mazur, A., & Lamb, T. (1980). Testosterone, status, and mood in human males. Hormones and Behavior, 14, 236–246.CrossRefPubMedGoogle Scholar
  31. McManus, I. C., & Bryden, M. P. (1991). Geschwind’s theory of cerebal lateralization: Developing a formal, causal model. Psychological Bulletin, 110, 237–253.PubMedGoogle Scholar
  32. Mendel, C. M. (1989). The free hormone hypothesis: A physiologically based mathematical model. Endocrine Reviews, 10, 232–274.PubMedGoogle Scholar
  33. Pardridge, W. (1991). Transport of thyroid hormones into tissues in vivo. In S. Wu (Ed.), Thyroid hormone metabolism (pp. 123–143). London: Blackwell.Google Scholar
  34. Pugeat, M., Garrel, D., Estour, B., Lejeune, H., Kurzer, M. S., Tourniaire, J., et al. (1988). Sex steroid-binding protein in nonendocrine diseases. Annals of the New York Academy of Sciences, 538, 235–247.PubMedGoogle Scholar
  35. Rada, R., Laws, D., & Kellner, R. (1976). Plasma testosterone levels in the rapist. Psychosomatic Medicine, 38, 257–268.PubMedGoogle Scholar
  36. Rosner, W. (1990). The functions of corticosteriod-binding globulin and sex-hormone binding globulin: Recent advances. Endocrine Reviews, 11, 80–91.PubMedGoogle Scholar
  37. Studer, L. H., & Reddon, J. R. (1998). Treatment may change risk prediction. Sexual Abuse: A Journal of Research and Treatment, 10, 175–181.Google Scholar
  38. Studer, L. H., Reddon, J. R., Roper, V., & Estrada, L. (1996). Phoenix: An inhospital treatment program for sex offenders. Journal of Offender Rehabilitation, 23, 91–97.Google Scholar
  39. Studer, L. H., Reddon, J. R., & Siminoski, K. G. (1997). Serum testosterone in adult sex offenders: A comparison between Caucasians and North American Indians. Journal of Clinical Psychology, 53, 375–385.PubMedGoogle Scholar
  40. Thompson, W. M., Dabbs, J. M., Jr., & Frady, R. L. (1990). Changes in saliva testosterone levels during a 90-day shock incarceration program. Criminal Justice and Behavior, 17, 246–252.Google Scholar
  41. Tsujimura, A., Matsumiya, K., Matsuoka, Y., Takahashi, T., Koga, M., Iwasa, A., et al. (2003). Bioavailable testosterone with age and erectile dysfunction. Journal of Urology, 170, 2345–2347.PubMedGoogle Scholar
  42. Wykes, T., Brammer, M., Mellers, J., Bray, P., Reeder, C., Williams, C., et al. (2002). Effects on the brain of a psychological treatment: Cognitive remediation therapy: Functional magnetic resonance imaging in schizophrenia. British Journal of Psychiatry, 181, 144–152.PubMedGoogle Scholar
  43. Yalom, I. D. (1995). The theory and practice of group psychotherapy (4th ed.). New York: Basic Books.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Lea H. Studer
    • 1
    • 2
  • A. Scott Aylwin
    • 1
  • John R. Reddon
    • 1
  1. 1.Phoenix ProgramAlberta Hospital EdmontonEdmontonCanada
  2. 2.Phoenix ProgramAlberta Hospital EdmontonEdmontonCanada

Personalised recommendations